A Bayesian time-to-event pharmacokinetic model for sequential phase I dose-escalation trials with multiple schedules

Burak Kürsad Günhan, Sebastian Weber, Abdelkader Seroutou +1

Phase I dose-escalation trials constitute the first step in investigating the safety of potentially promising drugs in humans. Conventional methods for phase I dose-escalation tria…